<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03609177</url>
  </required_header>
  <id_info>
    <org_study_id>18-276</org_study_id>
    <secondary_id>UG3AG060626</secondary_id>
    <nct_id>NCT03609177</nct_id>
  </id_info>
  <brief_title>Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly</brief_title>
  <acronym>ACP-PEACE</acronym>
  <official_title>Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Dana-Farber Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this research study, the investigators are working to help oncologists better serve&#xD;
      patients by delivering more patient-centered, goal-concordant care that may improve health&#xD;
      care delivery.&#xD;
&#xD;
      - It is expected that about 12,000 people will take part in this research study, 11,550 of&#xD;
      these patients, the vast majority, will be included only for medical record review.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to improve the quality of care provided to millions of older&#xD;
      Americans with cancer. The investigators are working to help oncologists better serve&#xD;
      patients by delivering more patient-centered, goal-concordant care that may dramatically&#xD;
      improve health care delivery.&#xD;
&#xD;
      This is pragmatic stepped wedge cluster randomized trial (SW-CRT) of a Comprehensive ACP&#xD;
      (Advance Care Planning) Program among older oncology patients. The ACP Program will include&#xD;
      training clinicians in communication skills and using video decision aids for participants.&#xD;
&#xD;
      - This study will involve medical record review of 11,550 people age 65 or older with&#xD;
      advanced cancer.&#xD;
&#xD;
      We will also recruit 450 eligible patients (150 patients from each of our three sites broken&#xD;
      down into 75 patients during the control phase and 75 patients during the intervention phase)&#xD;
      to conduct a survey for our secondary patient-centered outcomes (confidence, satisfaction&#xD;
      with physician communication, patient decisional satisfaction and regret). From among this&#xD;
      sub-group we will engage 240 participants (80 from each of our three sites broken down into&#xD;
      40 patients during the control phase and 40 patients during the intervention phase) in an&#xD;
      activity to film video declarations of their preferences.&#xD;
&#xD;
      During the first year, three pilot sites (one at each health care system) will trial the&#xD;
      intervention. The subjects recruited at these pilot sites will not be included in the final&#xD;
      analysis. Thus, the main trial will begin during year 2 and continue through year 5 with&#xD;
      recruitment of 11,550 subjects for the primary outcome at 36 oncology clinics. The first year&#xD;
      pilot will serve to inform the larger roll-out and the intervention may change during the&#xD;
      first year based on pilot-clinic experience.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Advance Care Planning Documentation</measure>
    <time_frame>4 years</time_frame>
    <description>Any advance directive (e.g., living will, POLST, etc.) and changes of resuscitation orders or any indication in the EHR of a goals-of-care or advance care planning conversation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Preferences for Resuscitation</measure>
    <time_frame>4 years</time_frame>
    <description>Documented choices regarding CPR and mechanical ventilation in the EHR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Palliative Care Consultation</measure>
    <time_frame>4 years</time_frame>
    <description>Use of palliative care services (consults, outpatient visits) in the EHR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Hospice Use</measure>
    <time_frame>4 years</time_frame>
    <description>Use of hospice documented in the EHR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confidence in Future Care</measure>
    <time_frame>4 years</time_frame>
    <description>(in person survey) patient confidence that they will receive the right care at the right time by their health system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Communication and Decisional Satisfaction</measure>
    <time_frame>4 years</time_frame>
    <description>(In person survey) patient satisfaction with communication and decision making</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decisional Regret</measure>
    <time_frame>4 years</time_frame>
    <description>(In person survey) patient regret regarding decision making</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">12000</enrollment>
  <condition>Other Cancer</condition>
  <arm_group>
    <arm_group_label>Advance Care Planning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>-Survey:&#xD;
A group of older patients with advanced cancer (N=450) will have a survey over the course of the 36 months of recruitment.&#xD;
Participants will be provided written copies of the questions to follow along during the interviews</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Advance Care Planning-Video Declaration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Video Declaration:&#xD;
From among this group of 450 participants, the video declaration of preferences activity will be conducted with 240 patients.&#xD;
For those participants that agree to the video declaration, they will proceed with recording of their video declarations&#xD;
The RA will begin by reading a standardized introduction to aid the subject do the video</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comprehensive Record Review of ACP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A review of Medical orders for resuscitation preferences in the electronic health record&#xD;
A review of Medical orders for Palliative care consultations preferences in the electronic health record&#xD;
A review of Medical orders for Hospice use preferences in the electronic health record</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Main Study Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with cancer being seen at the 36 oncology clinics will be exposed to clinicians who have had communication skills training (Vital Talk) and who are using video decision aids (ACP Decisions). Our main outcome is advance care planning documentation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinician Communication Skills Training</intervention_name>
    <description>Communication skills training</description>
    <arm_group_label>Advance Care Planning</arm_group_label>
    <arm_group_label>Advance Care Planning-Video Declaration</arm_group_label>
    <arm_group_label>Comprehensive Record Review of ACP</arm_group_label>
    <arm_group_label>Main Study Arm</arm_group_label>
    <other_name>Vital Talk Communication Skills Training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Advance Care Planning (ACP) Decisions Videos Decisions Aids</intervention_name>
    <description>ACP Decisions video decision aids</description>
    <arm_group_label>Advance Care Planning</arm_group_label>
    <arm_group_label>Advance Care Planning-Video Declaration</arm_group_label>
    <arm_group_label>Comprehensive Record Review of ACP</arm_group_label>
    <arm_group_label>Main Study Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Video Declarations (ViDec)</intervention_name>
    <description>Recording of patient advance care planning videos</description>
    <arm_group_label>Advance Care Planning-Video Declaration</arm_group_label>
    <arm_group_label>Comprehensive Record Review of ACP</arm_group_label>
    <arm_group_label>Main Study Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for clinics:&#xD;
&#xD;
        Clinic eligibility criteria include:&#xD;
&#xD;
          -  More than one oncologist&#xD;
&#xD;
          -  Serve a patient population that is at least 30% aged 65 or older&#xD;
&#xD;
          -  Disease-based oncology clinic&#xD;
&#xD;
        Subject Eligibility: (for the in-person surveys):&#xD;
&#xD;
        - Any patient affiliated with one of the study clinics who speaks English and is aged 65 or&#xD;
        older with advanced cancer is eligible for participation. Advanced cancer is defined as&#xD;
        metastatic disease for solid tumors and recurrent or refractory disease for hematological&#xD;
        malignancies. There are no exclusions based on gender, race, or ethnicity.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Individuals who are not yet adults (infants, children, teenagers)&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Prisoners&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James A. Tulsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dana-Farber Cancer Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James A. Tulsky, MD</last_name>
    <phone>617-582-9201</phone>
    <email>JamesA_Tulsky@dfci.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James A. Tulsky, MD</last_name>
      <phone>617-582-9201</phone>
      <email>JamesA_Tulsky@dfci.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>James A. Tulsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon Tilburt, MD</last_name>
      <phone>507-284-2269</phone>
      <email>Tilburt.jon@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Jon Tilburt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Martins-Welch, MD</last_name>
      <phone>516-708-2520</phone>
      <email>Dmartins1@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Diana Martins-Welch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke Health</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Pollak, MD</last_name>
      <phone>919-681-4757</phone>
      <email>Kathryn.pollak@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Kathryn Pollak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 25, 2018</study_first_submitted>
  <study_first_submitted_qc>July 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dana-Farber Cancer Institute</investigator_affiliation>
    <investigator_full_name>James A. Tulsky</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cancer Care</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 5, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT03609177/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

